Rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip
ICD-10 M05.559 is a billable code used to indicate a diagnosis of rheumatoid polyneuropathy with rheumatoid arthritis of unspecified hip.
Rheumatoid polyneuropathy is a complication of rheumatoid arthritis (RA), characterized by peripheral nerve involvement due to systemic inflammation. The condition can lead to symptoms such as pain, numbness, and weakness in the limbs. Anatomically, the hip joint, which is a ball-and-socket joint formed by the acetabulum of the pelvis and the head of the femur, may be affected by RA, leading to synovitis, joint erosion, and functional impairment. Clinically, patients may present with joint stiffness, swelling, and decreased range of motion, particularly in the hip, which can significantly impact mobility and quality of life. The pathophysiology involves autoimmune mechanisms where the immune system mistakenly attacks synovial tissues, leading to chronic inflammation and subsequent nerve damage. Diagnosis is often supported by clinical examination, imaging studies, and laboratory tests for rheumatoid factor and anti-citrullinated protein antibodies.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage, functional assessments to evaluate range of motion, and detailed notes on joint swelling and tenderness.
Patients may require joint injections, arthroscopy, or total hip arthroplasty due to severe joint damage.
Documentation must specify the degree of joint involvement and any surgical interventions performed.
Rheumatologic documentation should include laboratory results for inflammatory markers (ESR, CRP), disease activity scores (DAS28), and assessments of systemic involvement.
Management of RA flares, initiation of disease-modifying antirheumatic drugs (DMARDs), and monitoring for side effects.
Documenting the progression of the disease and any systemic manifestations is crucial.
Functional assessments should evaluate mobility, strength, and the need for assistive devices (e.g., walkers, canes).
Rehabilitation programs focusing on improving joint function and reducing pain through physical therapy.
Assessment of mobility limitations and the impact on daily activities is essential for treatment planning.
Used for joint injections in patients with RA affecting the hip joint.
Document the joint involved, indication for the procedure, and any imaging guidance used.
Orthopedic and rheumatologic considerations for joint management.
Common symptoms include pain, tingling, and numbness in the extremities, weakness, and difficulty with coordination, often exacerbated by the underlying rheumatoid arthritis.
